Science Explorer Back to mapMap
Discussion
Researcher · Prague University of Economics and Business · Czechia

Karel Helman

Karel Helman publishes mostly in Economics and Econometrics, Pathology and Forensic Medicine and Molecular Biology, on topics such as Chronic Lymphocytic Leukemia Research, Lymphoma Diagnosis and Treatment and Advanced Breast Cancer Therapies.

ORCID 0000-0001-7141-8074 OpenAlex
World rank
#2,126,035
of 7,710,434 ranked researchers
Rank in Czechia
#4,717
of 39,303
Works
54
Citations
544
Citations per work
10.1
h-index
9
i10-index 9Top 41% in Economics and Econometrics
Karel Helman

What does Karel Helman research?

Karel Helman's work is mostly in Medicine (19%), Economics, Econometrics and Finance (8%), Biochemistry, Genetics and Molecular Biology (7%).

Everything else: 33 works · 60.4% of their workHealth Sciences: 10 works · 19.1% of their workMedicine: 10 works · 19.1% of their workGenetics: 4 works · 6.8% of their workPathology and Forensic Medicine: 4 works · 6.8% of their workPulmonary and Respiratory Medicine: 3 works · 5.5% of their workLife Sciences: 7 works · 12.3% of their workBiochemistry, Genetics and Molecular Biology: 4 works · 6.8% of their workMolecular Biology: 4 works · 6.8% of their workAgricultural and Biological Sciences: 3 works · 5.5% of their workPlant Science: 3 works · 5.5% of their workSocial Sciences: 4 works · 8.2% of their workEconomics, Econometrics and Finance: 4 works · 8.2% of their workEconomics and Econometrics: 4 works · 8.2% of their workTHEIR WORKKarel Helman54works
Life Sciences12%Health Sciences19%Social Sciences8%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
  1. Everything else3360.4%
    1. Medicine1019.1%
    1. Biochemistry, Genetics and Molecular Biology46.8%
    2. Agricultural and Biological Sciences35.5%
    1. Economics, Econometrics and Finance48.2%
  1. 1Economics and Econometrics8% of their works
  2. 2Pathology and Forensic Medicine7% of their works
  3. 3Molecular Biology7% of their works
  4. 4Genetics7% of their works
  5. 5Pulmonary and Respiratory Medicine6% of their works
  6. 6Plant Science6% of their works

Research topics

Which keywords describe Karel Helman's research?

The keywords of their largest research topics: Rituximab, Chronic Lymphocytic Leukemia, Classification, Genomic Aberrations, Lymphoma, Climate Change, Breast Cancer and CDK4/6 Inhibitors.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.

All 18 words, with their numbers
  1. Rituximab102 topics
  2. Chronic Lymphocytic Leukemia51 topic
  3. Classification51 topic
  4. Genomic Aberrations51 topic
  5. Lymphoma51 topic
  6. Climate Change42 topics
  7. Breast Cancer31 topic
  8. CDK4/6 Inhibitors31 topic
  9. Ageing Population21 topic
  10. Cell Cycle21 topic
  11. Ecosystem21 topic
  12. Energy Efficiency21 topic
  13. Extreme Events21 topic
  14. Global Warming21 topic
  15. Health Care Expenditure21 topic
  16. Land Cover21 topic
  17. Rebound Effect21 topic
  18. p5321 topic

Where does Karel Helman work?

Karel Helman's main affiliation in the publication record is Prague University of Economics and Business, Czechia.

How many publications and citations does Karel Helman have?

OpenAlex counts 54 works and 544 citations for Karel Helman, an h-index of 9, ranking #2,126,035 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Karel Helman. Posts are plain text and can be reported.